Physician
Oncology
Dr. Bruce J. Dezube, MD
|
|
Give Review
Bruce Dezube practices Oncology. He studied medicine at Tufts University School of Medicine. Tufts University School of Medicine has a rank of 49 in research and a 52 in primary care He over the years received 1 awards: "Super Doctor". Bruce J. Dezube is also published. He has 102 publications published. The lastest publication: "Phase I Study of the Novel Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (MLN4924) in Patients with Relapsed/Refractory Multiple Myeloma or Lymphoma.'
Publications
- Phase I Study of the Novel Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (MLN4924) in Patients with Relapsed/Refractory Multiple Myeloma or Lymphoma.
- Cutaneous keratoacanthomas/squamous cell carcinomas associated with neutralization of transforming growth factor β by the monoclonal antibody fresolimumab (GC1008).
- First-in-Human Phase 1 Dose Escalation Study of a Second-Generation Non-Ansamycin HSP90 Inhibitor, AT13387, in Patients with Advanced Solid Tumors.
- A phase 1/pharmacokinetic study of sunitinib in combination with highly active antiretroviral therapy in human immunodeficiency virus-positive patients with cancer: AI...
- Phase II Trial of Imatinib in AIDS-Associated Kaposi's Sarcoma: AIDS Malignancy Consortium Protocol 042.
- Pegylated liposomal doxorubicin, rituximab, cyclophosphamide, vincristine, and prednisone in AIDS-related lymphoma: AIDS Malignancy Consortium Study 047.
- The rising challenge of non-AIDS-defining cancers in HIV-infected patients.
- Cannabidiol inhibits growth and induces programmed cell death in kaposi sarcoma-associated herpesvirus-infected endothelium.
- A Phase I First-in-Human Trial of Bardoxolone Methyl in Patients with Advanced Solid Tumors and Lymphomas.
- Rapamycin with Antiretroviral Therapy in AIDS-Associated Kaposi Sarcoma: An AIDS Malignancy Consortium Study.
- Personalized medicine for acute myelogenous leukemia-At the entrance gate.
- Nuclear factor kappa B (NFkB) pathway associated biomarkers in AIDS defining malignancies.
- Fine needle aspiration of salivary gland masses in HIV-infected patients.
- Pilot study evaluating the interaction between paclitaxel and protease inhibitors in patients with human immunodeficiency virus-associated Kaposi's sarcoma: an Eastern...
- Phase II AIDS Malignancy Consortium trial of topical halofuginone in AIDS-related Kaposi sarcoma.
- Human immunodeficiency virus-associated primary lung cancer in the era of highly active antiretroviral therapy: a multi-institutional collaboration.
- Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.
- Fine needle aspiration of breast masses in HIV-infected patients: results from a large series.
- Randomized trial of paclitaxel versus pegylated liposomal doxorubicin for advanced human immunodeficiency virus-associated Kaposi sarcoma: evidence of symptom palliati...
- Time for oncologists to opt in for routine opt-out HIV testing?
- Frequency of occult high-grade squamous intraepithelial neoplasia and invasive cancer within anal condylomata in men who have sex with men.
- AIDS-related Kaposi's sarcoma of the gastrointestinal tract.
- Primary esophageal carcinoma in the era of highly active antiretroviral therapy.
- Monocytes tied to HIV-associated thrombosis.
- Letter: Kaposi sarcoma versus nephrogenic systemic fibrosis.
- Molecular and clinical assessment in the treatment of AIDS Kaposi sarcoma with valproic Acid.
- Human immunodeficiency virus-associated lung carcinoma presenting as cutaneous metastases.
- Human immunodeficiency virus-associated adenocarcinoma of the colon: clinicopathologic findings and outcome.
- The inflammatory component of Kaposi sarcoma.
- Targeted therapies to treat non-AIDS-defining cancers in patients with HIV on HAART therapy: treatment considerations and research outlook.
- A 57-year-old HIV-positive man with persistent fever, weight loss, and pancytopenia.
- Tumor suppressor microRNAs are underrepresented in primary effusion lymphoma and Kaposi sarcoma.
- Images in HIV/AIDS. Unsuspected parvovirus B19 infection in a person with AIDS.
- CCR5 antagonists in the treatment of HIV-infected persons: is their cancer risk increased, decreased, or unchanged.
- Effects of chemotherapy in AIDS-associated non-Hodgkin's lymphoma on Kaposi's sarcoma herpesvirus DNA in blood.
- Editorial comment: screening for anal dysplasia--are we on the same page?
- Frequency and significance of HIV infection among patients diagnosed with thrombotic thrombocytopenic purpura.
- Pre-micro RNA signatures delineate stages of endothelial cell transformation in Kaposi sarcoma.
- Detection of JC virus DNA and proteins in the bone marrow of HIV-positive and HIV-negative patients: implications for viral latency and neurotropic transformation.
- Gastroenteropancreatic neuroendocrine tumors in patients with HIV infection: a trans-Atlantic series.
- Images in HIV/AIDS. Fatal HIV-associated anaplastic large-cell lymphoma.
- Evolving spectrum and incidence of non-AIDS-defining malignancies.
- Images in HIV/AIDS. HIV and viral hepatitis coinfection.
- HIV/AIDS: epidemiology, pathophysiology, and treatment of Kaposi sarcoma-associated herpesvirus disease: Kaposi sarcoma, primary effusion lymphoma, and multicentric Ca...
- HIV-associated plasmablastic lymphoma: lessons learned from 112 published cases.
- Human immunodeficiency virus--associated renal cell carcinoma: a transatlantic case series.
- Images in HIV/AIDS. HIV-associated toxic megacolon.
- HIV-associated multicentric Castleman's disease.
- Activity and safety of pegylated liposomal doxorubicin as first-line therapy in the treatment of non-visceral classic Kaposi's sarcoma: a multicenter study.
- Pitfalls of diagnosis based on abnormal flow cytometry and [(18)F]fluorodeoxyglucose positron emission tomography.
- Images in HIV/AIDS. Sweet syndrome and syphilis in an HIV-infected person.
- Pegylated liposomal doxorubicin as second-line therapy in the treatment of patients with advanced classic Kaposi sarcoma: a retrospective study.
- Editorial comment: hemophagocytic syndrome--an HIV-associated quagmire.
- Multicentric Castleman's disease masquerading as HIV-related lymphoma.
- Protein electrophoresis and immunoglobulin analysis in HIV-infected patients.
- Editorial comment: plasmablastic lymphoma--a diagnostic and therapeutic puzzle.
- Images in HIV/AIDS. Pericardial primary effusion lymphoma.
- Editorial comment: bone lesions in Kaposi sarcoma.
- Kaposi sarcoma of the musculoskeletal system: a review of 66 patients.
- HIV-associated intramammary lymphadenopathy.
- Phase I clinical trial of STA-4783 in combination with paclitaxel in patients with refractory solid tumors.
- Emerging targets and novel strategies in the treatment of AIDS-related Kaposi's sarcoma: bidirectional translational science.
- HIV-associated monoclonal gammopathy: a retrospective analysis of 25 patients.
- Higher prevalence of monoclonal gammopathy of undetermined significance in African Americans than whites--the unknown role of underlying HIV infection.
- HIV-associated anal squamous cell cancer: an otherwise preventable disease.
- The growing problem of non-AIDS-defining malignancies in HIV.
- Signal transduction targets in Kaposi's sarcoma.
- Ovarian carcinoma with thyroid metastases causing clinical hypothyroidism: a case report.
- Images in HIV/AIDS. AIDS-associated intestinal cryptosporidiosis.
- A phase I study of ultra low dose interleukin-2 and stem cell factor in patients with HIV infection or HIV and cancer.
- Case of fatal sickle cell intrahepatic cholestasis despite use of exchange transfusion in an African-American patient.
- Images in HIV/AIDS. HIV-associated squamous cell carcinoma of the anus.
- Kaposi sarcoma of the larynx.
- Randomized phase II trial of matrix metalloproteinase inhibitor COL-3 in AIDS-related Kaposi's sarcoma: an AIDS Malignancy Consortium Study.
- Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1.
- Kaposi's sarcoma and pregnancy.
- A6, a urokinase plasminogen activator (uPA)-derived peptide in patients with advanced gynecologic cancer: a phase I trial.
- Extracavitary primary effusion lymphoma of the anorectum.
- HHV8 is not limited to Kaposi's sarcoma.
- HIV and the breast.
- Novel cellular genes essential for transformation of endothelial cells by Kaposi's sarcoma-associated herpesvirus.
- C-Kit (CD117) expression in AIDS-related, classic, and African endemic Kaposi sarcoma.
- AIDS-related malignancies: emerging challenges in the era of highly active antiretroviral therapy.
- Unusual Sites of Malignancies: CASE 3. AIDS-related Kaposi's sarcoma of the gastrointestinal tract.
- Imatinib-induced regression of AIDS-related Kaposi's sarcoma.
- Angiogenesis inhibitor IM862 is ineffective against AIDS-Kaposi's sarcoma in a phase III trial, but demonstrates sustained, potent effect of highly active antiretrovir...
- Spectrum of human papillomavirus-related dysplasia and carcinoma of the anus in HIV-infected patients.
- Capravirine, a nonnucleoside reverse-transcriptase inhibitor in patients infected with HIV-1: a phase 1 study.
- AIDS-related non-Hodgkin lymphoma: still a problem in the era of HAART.
- Unusual sites of Hodgkin's lymphoma: CASE 1. HIV-associated Hodgkin's lymphoma of the stomach.
- Thrombotic complications in patients infected with HIV in the era of highly active antiretroviral therapy: a case series.
- Advances in the pathobiology and treatment of Kaposi sarcoma.
- Plasma cell disorders in HIV-infected patients: from benign gammopathy to multiple myeloma.
- Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma-associated herpesvirus.
- High resolution anoscopy findings for men who have sex with men: inaccuracy of anal cytology as a predictor of histologic high-grade anal intraepithelial neoplasia and...
- Management of AIDS-related Kaposi sarcoma: advances in target discovery and treatment.
- Reasons for a deficit of breast cancer among HIV-infected patients.
- Kaposi's sarcoma.
- Human immunodeficiency virus-associated hemophagocytosis with iron-deficiency anemia and massive splenomegaly.
- HIV infection masquerading as monoclonal gammopathy of undetermined significance.
- Phase I Study of the Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (TAK-924/MLN4924) in Patients with Advanced Solid Tumors.
Schools
Tufts University School Of Medicine
New England Med Center
Beth Israel Deaconess Hospital
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- Super Doctor
Education
-
Beth Israel Deaconess Medical Center -
Tufts Medical Center -
Tufts University School of Medicine
Helpful Reviews
Similar Doctors
|
|
Dr. Mary L. Peters, MD |
|
|
Dr. Raj K. Gopal, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carolyn N. Krasner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alice T. Shaw, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kirstine Y. Oh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marian H. Harris, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dimitrios Spentzos, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anish V. Sharda, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alexandra Drakaki, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Matthew B. Yurgelun, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Barrett J. Rollins, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dejan Juric, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeffrey A. Meyerhardt, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David E. Fisher, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lowell E. Schnipper, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joan H. Goldberg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Beverly Moy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew J. Yee, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert J. Friedlander Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dongsheng Xu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amy E. Fallon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sun Y. Oh, MD |